TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9932939

Group type: EXPERIMENTAL
Intervention: Presence of cerebral abnormalities on quantitative MRI analysis
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Global memory impairment
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Bilateral memory deficits
Number of subjects: 28
Study: 7788197

Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Thiopentone 1.5 mg/kg
Number of subjects: 24
Study: 2316283

Group type: EXPERIMENTAL
Intervention: Purified chick embryo cell rabies vaccine (Rabipur)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard NIH test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative in vivo methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified ABT
Number of subjects: 0
Study: 340117

Group type: EXPERIMENTAL
Intervention: Mestranol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gestronol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 31174213

Group type: COMPARATOR
Intervention: Lean men
Number of subjects: 24

Group type: COMPARATOR
Intervention: Obese men
Number of subjects: 24
Study: 28972004

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin
Number of subjects: 18144
Study: 25468944

Group type: EXPERIMENTAL
Intervention: DM2+Met
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DM2
Number of subjects: 3

Group type: COMPARATOR
Intervention: CON
Number of subjects: 3
Study: 23441598

Group type: EXPERIMENTAL
Intervention: Sevoflurane and 8 mg of ondansetron
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Propofol and 8 mg of ondansetron
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Sevoflurane combined with propofol and 8 mg of ondansetron
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 240

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sevoflurane combined with propofol
Number of subjects: 240
Study: 21054554

Group type: EXPERIMENTAL
Intervention: Zirconia (ZrO(2)) abutments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Titanium (Ti) abutments
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both ZrO(2) and Ti abutments
Number of subjects: 20
Study: 19750874

Group type: EXPERIMENTAL
Intervention: Moving visual field (upward or downward)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Stationary visual field
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no motor responses)
Number of subjects: 36
Study: 17209191

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Formula with DHA
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Breastfeeding and Formula Feeding
Number of subjects: 262
Study: 15146102

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: Combined conjugated equine estrogen 0.625 mg and medroxyprogesterone acetate 5 mg daily (CCEP)
Number of subjects: 59
Study: 11593317

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with doxorubicin/G-CSF followed by high-dose chemotherapy (HDC) with CTCb and melphalan, and dose-escalated paclitaxel at 475 mg/m2
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with stem cell support
Number of subjects: 26
Study: 9817491

Group type: EXPERIMENTAL
Intervention: Epicardial implantable cardioverter-defibrillator (ICD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No additional treatment (CABG alone)
Number of subjects: 0
Study: 8158507

Group type: EXPERIMENTAL
Intervention: Strontium-based desensitizing toothpaste 1
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Strontium-based desensitizing toothpaste 2
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional fluoride toothpaste
Number of subjects: 119
Study: 2966193

Group type: EXPERIMENTAL
Intervention: Low-dose adrenaline infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study: 5470431

Group type: EXPERIMENTAL
Intervention: Intravenous bicarbonate postoperatively
Number of subjects: 181

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 181
Study: 29793387

Group type: EXPERIMENTAL
Intervention: Home-based telehealth monitoring
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 171
Study: 28323701

Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PVP)
Number of subjects: 163
Study: 26377342

Group type: EXPERIMENTAL
Intervention: ivabradine (titrated to 7.5 mg bid)
Number of subjects: 6505

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6505
Study: 22640686

Group type: EXPERIMENTAL
Intervention: Water consumption
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Fruit juice intake
Number of subjects: 1134
Study: 21736934

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4))
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 18463448

Group type: EXPERIMENTAL
Intervention: 2‐compound scalp formulation (calcipotriol plus betamethasone dipropionate)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Betamethasone dipropionate in the same vehicle
Number of subjects: 218
Study: 16796097

Group type: EXPERIMENTAL
Intervention: Logical presentation of pictures (e.g., enter cafeteria, pick up tray, stand in line, select food)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Random presentation of pictures
Number of subjects: 72
Study: 12900588

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg (up-titrated to 80 mg if needed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan 50 mg (up-titrated to 100 mg if needed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telmisartan 40/80 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan 50/100 mg
Number of subjects: 0
Study: 11035321

Group type: EXPERIMENTAL
Intervention: Cerclage (McDonald cerclage)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No cerclage
Number of subjects: 61
Study: 9371668

Group type: EXPERIMENTAL
Intervention: MMF 3 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMF 2 g/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZA 1-2 mg/kg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: AZA
Number of subjects: 0

Group type: COMPARATOR
Intervention: MMF 2 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: MMF 3 g
Number of subjects: 0
Study: 1405686

Group type: EXPERIMENTAL
Intervention: Low-dose steroids (10 mg methylprednisolone IV intraoperatively, 10 mg IM daily for 10 days, 250 mg hydrocortisone succinate endobronchially before extubation, 5 mg methylprednisolone daily in aerosol solution)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No steroids (control group)
Number of subjects: 20
Study: 3893610

Group type: EXPERIMENTAL
Intervention: Conray 420
Number of subjects: 482

Group type: COMPARATOR
Intervention: Conray 280
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Uromiro Sodium 300
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Niopam 370
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Urografin 370
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Minor reactions
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Non-ionic agents
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Sodium salt of an ionic agent
Number of subjects: 482
Study: 31505986

Group type: EXPERIMENTAL
Intervention: Locally acting generic drug (T)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innovator drug (R)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 0
Study: 29570772

Group type: EXPERIMENTAL
Intervention: 81 mg daily aspirin for 3 years
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: 325 mg daily aspirin for 3 years
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Folic acid 1 mg daily for 6 years
Number of subjects: 1121
Study: 26567804

Group type: EXPERIMENTAL
Intervention: Critical Time Intervention (CTI)
Number of subjects: 0
Study: 24453026

Group type: EXPERIMENTAL
Intervention: T1-weighted pre- and post-contrast (T1+Gd) images
Number of subjects: 67

Group type: COMPARATOR
Intervention: Short tau inversion recovery (STIR) images
Number of subjects: 67
Study: 22534058

Group type: EXPERIMENTAL
Intervention: TVT-O (inside-out approach)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: TOT-Aris (outside-in approach)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 341
Study: 20852299

Group type: EXPERIMENTAL
Intervention: Intracardiac Echocardiography (ICE)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Transesophageal Echocardiography (TEE)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: ICE
Number of subjects: 95

Group type: COMPARATOR
Intervention: TEE
Number of subjects: 95
Study: 17987879

Group type: EXPERIMENTAL
Intervention: meridol toothbrush
Number of subjects: 171

Group type: COMPARATOR
Intervention: ADA toothbrush
Number of subjects: 171
Study: 15860185

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 14920

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 14920

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 14920

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14920
Study: 12421155

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A for tension-type headache
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A for migraine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A for cervicogenic headache
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A for cluster headache
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A for chronic paroxysmal hemicrania
Number of subjects: 0
Study: 10350245

Group type: EXPERIMENTAL
Intervention: 15 mg/kg/day of tirilazad mesylate
Number of subjects: 819

Group type: COMPARATOR
Intervention: Placebo (citrate vehicle)
Number of subjects: 819
Study: 8596222

Group type: EXPERIMENTAL
Intervention: Experimental schedule (9 visits)
Number of subjects: 2764

Group type: COMPARATOR
Intervention: Control schedule (14 visits)
Number of subjects: 2764
Study: 2006660

Group type: EXPERIMENTAL
Intervention: Active treatment with a combination of triamterene and hydrochlorothiazide
Number of subjects: 840

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 840
Study: 7341219

Group type: EXPERIMENTAL
Intervention: Atropine (0.5 mg s.c.)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.5 mg s.c.)
Number of subjects: 18
Study: 31050818

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA)
Number of subjects: 828

Group type: COMPARATOR
Intervention: Inhalational anesthesia (IA)
Number of subjects: 828
Study: 30462194

Group type: EXPERIMENTAL
Intervention: Endoscopic dilatation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (sham dilatation)
Number of subjects: 41
Study: 27553192

Group type: EXPERIMENTAL
Intervention: Intranasal insulin lispro (48 or 80 IU followed by 160 IU)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intranasal insulin lispro (24 IU/kg or 192 IU/kg) in beagle dogs
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intranasal insulin lispro
Number of subjects: 14
Study: 26549483

Group type: EXPERIMENTAL
Intervention: One-day practical course in surgical skills for maxillofacial surgery
Number of subjects: 54
Study: 24387642

Group type: COMPARATOR
Intervention: Facial Mask (FM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Helmet Standard (HS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Helmet Next (HN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Helmet Next (HN) at increased settings
Number of subjects: 12
Study: 22385260

Group type: EXPERIMENTAL
Intervention: 200 mg systemic doxycycline (DOXY) for 7 days after surgery
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (PLAC) for 7 days after surgery
Number of subjects: 61
Study: 19670918

Group type: EXPERIMENTAL
Intervention: pioglitazone (15-45 mg once daily)
Number of subjects: 2097

Group type: COMPARATOR
Intervention: glibenclamide (5-15 mg once daily)
Number of subjects: 2097

Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 2097

Group type: COMPARATOR
Intervention: glibenclamide
Number of subjects: 2097
Study: 17454066

Group type: EXPERIMENTAL
Intervention: Galantamine hydrobromide dispersible tablet (10 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference formulation (conventional tablet)
Number of subjects: 18
Study: 15281473

Group type: EXPERIMENTAL
Intervention: Budesonide aqueous nasal spray (64 microg/d)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 12215757

Group type: EXPERIMENTAL
Intervention: Ximelagatran/Melagatran (highest dose)
Number of subjects: 4664

Group type: EXPERIMENTAL
Intervention: Ximelagatran/Melagatran (24 mg, twice daily)
Number of subjects: 4664

Group type: COMPARATOR
Intervention: Enoxaparin (40 mg, once daily)
Number of subjects: 4664

Group type: COMPARATOR
Intervention: Dalteparin (5000 IE, once daily)
Number of subjects: 4664

Group type: EXPERIMENTAL
Intervention: Melagatran (3 mg, twice daily)
Number of subjects: 4664
Study: 9579164

Group type: EXPERIMENTAL
Intervention: Regular inhaled corticosteroids
Number of subjects: 50

Group type: COMPARATOR
Intervention: Not receiving regular corticosteroids
Number of subjects: 50
Study: 8563223

Group type: EXPERIMENTAL
Intervention: IgA and IgG gliadin antibodies (AGA) and IgA endomysium antibodies (EMA) in coeliac disease (CD)
Number of subjects: 3783

Group type: COMPARATOR
Intervention: EMA
Number of subjects: 3783

Group type: COMPARATOR
Intervention: IgA AGA
Number of subjects: 3783

Group type: COMPARATOR
Intervention: IgG AGA
Number of subjects: 3783

Group type: EXPERIMENTAL
Intervention: Combined determination of EMA and AGA
Number of subjects: 3783

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 3783
Study: 2096204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Initial 24 h BP
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Waking hours
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: White coat-induced BP increase
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Alarm reaction to physician presence
Number of subjects: 21
Study: 657100

Group type: EXPERIMENTAL
Intervention: G.A.T.L.A. protocol (vincristine-prednisone plus surgery and/or radiotherapy, craniocervical radiotherapy, intrathecal methotrexate, anti-leukemia and anti-lymphoma treatments)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No uniform treatment (1966-1972 group)
Number of subjects: 122
Study: 31489024

Group type: EXPERIMENTAL
Intervention: Mild hypothermia combined with micro‐traumatic evacuation of cerebral hemorrhage
Number of subjects: 136

Group type: COMPARATOR
Intervention: Micro‐traumatic evacuation of cerebral hemorrhage with conventional symptomatic treatment (Control)
Number of subjects: 136
Study: 28694269

Group type: EXPERIMENTAL
Intervention: Training and support
Number of subjects: 120

Group type: COMPARATOR
Intervention: Financial reimbursement
Number of subjects: 120

Group type: COMPARATOR
Intervention: Electronic brief advice
Number of subjects: 120
Study: 25553336

Group type: EXPERIMENTAL
Intervention: Coping strategies training program (6 sessions, 1.5 hours each)
Number of subjects: 87
Study: 23386160

Group type: EXPERIMENTAL
Intervention: Laparoscopic interval appendectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open interval appendectomy
Number of subjects: 100
Study: 21350041

Group type: EXPERIMENTAL
Intervention: Varenicline with different modes of cessation counseling
Number of subjects: 1161
Study: 19048594

Group type: EXPERIMENTAL
Intervention: Cytology combined with hrHPV detection
Number of subjects: 210

Group type: COMPARATOR
Intervention: Cytology alone
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Combined testing strategy (cytology and hrHPV)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cytology and hrHPV testing
Number of subjects: 210
Study: 17874489

Group type: EXPERIMENTAL
Intervention: Coitus at least once weekly
Number of subjects: 76

Group type: COMPARATOR
Intervention: No coitus
Number of subjects: 76
Study: 15181067

Group type: EXPERIMENTAL
Intervention: Troglitazone, 400 mg/d (early intervention)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (late intervention)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Troglitazone (after developing diabetes)
Number of subjects: 126
Study: 11747172

Group type: EXPERIMENTAL
Intervention: Hand-mounted JoStent
Number of subjects: 505

Group type: COMPARATOR
Intervention: Premounted Multi-Link Duet stent
Number of subjects: 505
Study: 9258733

Group type: EXPERIMENTAL
Intervention: Immediate cytologic evaluation (ICE)
Number of subjects: 80
Study: 8334584

Group type: EXPERIMENTAL
Intervention: Segmentally applied TENS
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Heterosegmentally applied TENS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 10
Study: 3706675

Group type: EXPERIMENTAL
Intervention: New inhalation technique (shrug of the shoulder method)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional inhalation technique
Number of subjects: 20
Study: 30498336

Group type: EXPERIMENTAL
Intervention: Cucumis sativus extract (CSE) 10 mg twice daily
Number of subjects: 122

Group type: COMPARATOR
Intervention: Glucosamine-chondroitin (GC) 1,350 mg twice daily
Number of subjects: 122
Study: 27213735

Group type: EXPERIMENTAL
Intervention: Propofol/Ketamine (1:1)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol/Ketamine (3:1)
Number of subjects: 100
Study: 25219207

Group type: EXPERIMENTAL
Intervention: Nasal endoscope
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (routine method of intraoral path)
Number of subjects: 66
Study: 23730956

Group type: EXPERIMENTAL
Intervention: Trichuris suis ova (TSO) 500
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trichuris suis ova (TSO) 7500
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trichuris suis ova (TSO) 2500
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 20965814

Group type: EXPERIMENTAL
Intervention: Low-intensity anticoagulant treatment with warfarin (INR maintained between 1.5 and 2.0)
Number of subjects: 845

Group type: COMPARATOR
Intervention: Standard anticoagulant intensity with warfarin (INR maintained between 2.0 and 3.0)
Number of subjects: 845
Study: 18981357

Group type: EXPERIMENTAL
Intervention: Family history assessment
Number of subjects: 1342

Group type: COMPARATOR
Intervention: Genetic test results
Number of subjects: 1342
Study: 12081674

Group type: EXPERIMENTAL
Intervention: Glycolic acid peels (20%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Microdermabrasion (mild setting)
Number of subjects: 10
Study: 9795298

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 409

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 409
Study: 7865650

Group type: EXPERIMENTAL
Intervention: Phenolphthalein 30 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenolphthalein glucuronide equivalent to 30 mg phenolphthalein
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenolphthalein (doses of 15, 30, 45, 60, 75, and 90 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenolphthalein glucuronide (doses of 24, 48, 72, 96, 120, and 144 mg)
Number of subjects: 10
Study: 2802557

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg) twice daily for 3 days
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg) twice daily for 7 days
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ofloxacin (300 mg) twice daily for 7 days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (160/800 mg) twice daily for 7 days
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 74
Study: 1096686

Group type: EXPERIMENTAL
Intervention: Pyridoxine therapy (200 mg daily)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Pyridoxine (50 mg and 100 mg)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 76
Study: 31629372

Group type: EXPERIMENTAL
Intervention: Oral Zhiqiao Gancao (ZQGC) decoction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bed rest
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral anti-inflammatory drug celecoxib
Number of subjects: 0
Study: 28243790

Group type: EXPERIMENTAL
Intervention: Bipolar TURP
Number of subjects: 497

Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 497
Study: 24151982

Group type: EXPERIMENTAL
Intervention: Controlled-frequency breath (CFB) swimming
Number of subjects: 18

Group type: COMPARATOR
Intervention: Stroke-matched (SM) condition
Number of subjects: 18
Study: 23324098

Group type: EXPERIMENTAL
Intervention: AZD1940 (400 μg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: AZD1940 (800 μg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 20971614

Group type: EXPERIMENTAL
Intervention: GH+Ox 0.03 mg/kg/d
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: GH+Ox 0.06 mg/kg/d
Number of subjects: 133

Group type: COMPARATOR
Intervention: GH+Pl (placebo)
Number of subjects: 133
Study: 19935025

Group type: EXPERIMENTAL
Intervention: Periodontal treatment starting around 20 weeks of gestation (n=542)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group receiving no treatment until 6 weeks after pregnancy (n=540)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 1000
Study: 16908486

Group type: EXPERIMENTAL
Intervention: TGN1412 (anti-CD28 monoclonal antibody)
Number of subjects: 6
Study: 15114598

Group type: EXPERIMENTAL
Intervention: Chronic transfusion therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Asymptomatic SCD patients
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ACS
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: APE
Number of subjects: 61